JP2016501844A5 - - Google Patents

Download PDF

Info

Publication number
JP2016501844A5
JP2016501844A5 JP2015540743A JP2015540743A JP2016501844A5 JP 2016501844 A5 JP2016501844 A5 JP 2016501844A5 JP 2015540743 A JP2015540743 A JP 2015540743A JP 2015540743 A JP2015540743 A JP 2015540743A JP 2016501844 A5 JP2016501844 A5 JP 2016501844A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
compound according
acceptable salt
compound
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2015540743A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016501844A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/067466 external-priority patent/WO2014074365A1/en
Publication of JP2016501844A publication Critical patent/JP2016501844A/ja
Publication of JP2016501844A5 publication Critical patent/JP2016501844A5/ja
Ceased legal-status Critical Current

Links

JP2015540743A 2012-11-06 2013-10-30 MoGAT−2阻害剤として有用な新規のベンジルスルホンアミド化合物 Ceased JP2016501844A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP12382431.0 2012-11-06
EP12382431 2012-11-06
US201361748935P 2013-01-04 2013-01-04
US61/748,935 2013-01-04
PCT/US2013/067466 WO2014074365A1 (en) 2012-11-06 2013-10-30 Novel benzyl sulfonamide compounds useful as mogat-2 inhibitors

Publications (2)

Publication Number Publication Date
JP2016501844A JP2016501844A (ja) 2016-01-21
JP2016501844A5 true JP2016501844A5 (OSRAM) 2016-11-24

Family

ID=47143796

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015540743A Ceased JP2016501844A (ja) 2012-11-06 2013-10-30 MoGAT−2阻害剤として有用な新規のベンジルスルホンアミド化合物

Country Status (11)

Country Link
US (1) US9416138B2 (OSRAM)
EP (1) EP2917194B1 (OSRAM)
JP (1) JP2016501844A (OSRAM)
KR (1) KR20150063519A (OSRAM)
CN (1) CN104768941B (OSRAM)
AU (1) AU2013341584A1 (OSRAM)
BR (1) BR112015009567A2 (OSRAM)
CA (1) CA2886831A1 (OSRAM)
EA (1) EA201590696A1 (OSRAM)
MX (1) MX2015005739A (OSRAM)
WO (1) WO2014074365A1 (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2807147A1 (en) 2012-01-23 2014-12-03 Eli Lilly and Company Phenyl methanesulfonamide derivatives useful as mgat - 2 inhibitors
SG11201404508XA (en) 2012-01-31 2014-10-30 Lilly Co Eli Novel morpholinyl derivatives useful as mogat-2 inhibitors
US10335401B2 (en) 2015-12-21 2019-07-02 Shionogi & Co., Ltd. Non-aromatic heterocyclic derivative having MGAT2 inhibitory activity
TWI782056B (zh) 2017-07-14 2022-11-01 日商鹽野義製藥股份有限公司 具有mgat2抑制活性的縮合環衍生物
KR20210114001A (ko) 2019-01-11 2021-09-17 시오노기 앤드 컴파니, 리미티드 Mgat2 저해 활성을 갖는 다이하이드로피라졸로피라지논 유도체

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0784612A1 (en) * 1994-10-04 1997-07-23 Fujisawa Pharmaceutical Co., Ltd. Urea derivatives and their use as acat-inhibitors
GB9702194D0 (en) 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
EA012260B1 (ru) * 2002-01-29 2009-08-28 Лаборатуар Сероно Са ЗАМЕЩЁННЫЕ ПРОИЗВОДНЫЕ МЕТИЛЕНАМИДА В КАЧЕСТВЕ МОДУЛЯТОРОВ ПРОТЕИНТИРОЗИНФОСФАТАЗ (PTPs)
NZ550114A (en) * 2004-04-20 2011-02-25 Transtech Pharma Inc Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
EP1659113A1 (en) 2004-11-08 2006-05-24 Evotec AG Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1)
EP1655283A1 (en) * 2004-11-08 2006-05-10 Evotec OAI AG 11beta-HSD1 Inhibitors
US8232282B2 (en) 2006-09-28 2012-07-31 Dainippon Sumitomo Pharma Co., Ltd. Compound having bicyclic pyrimidine structure and pharmaceutical composition comprising the same
TW200831092A (en) * 2006-12-21 2008-08-01 Astrazeneca Ab Therapeutic agents
CA2751244A1 (en) 2009-02-23 2010-08-26 Msd K.K. Pyrimidin-4(3h)-one derivatives
CN103772239B (zh) * 2009-04-20 2017-04-12 Abbvie 公司 酰胺和脒衍生物和其用途
US8507493B2 (en) * 2009-04-20 2013-08-13 Abbvie Inc. Amide and amidine derivatives and uses thereof
EP2807147A1 (en) 2012-01-23 2014-12-03 Eli Lilly and Company Phenyl methanesulfonamide derivatives useful as mgat - 2 inhibitors
AR089771A1 (es) 2012-01-31 2014-09-17 Lilly Co Eli Derivados de bencil sulfonamida utiles como inhibidores de mogat-2
SG11201404508XA (en) 2012-01-31 2014-10-30 Lilly Co Eli Novel morpholinyl derivatives useful as mogat-2 inhibitors

Similar Documents

Publication Publication Date Title
JP2013537203A5 (OSRAM)
JP2017504635A5 (OSRAM)
JP2013032389A5 (OSRAM)
JP2018529650A5 (OSRAM)
JP2016530259A5 (OSRAM)
JP2015537020A5 (OSRAM)
JP2014500861A5 (OSRAM)
JP2016514159A5 (OSRAM)
JP2008531599A5 (OSRAM)
JP2012508252A5 (OSRAM)
JP2016506958A5 (OSRAM)
JP2015509534A5 (OSRAM)
JP2015509535A5 (OSRAM)
JP2016503799A5 (OSRAM)
JP2016505614A5 (OSRAM)
JP2016516699A5 (OSRAM)
JP2016540742A5 (OSRAM)
JP2017501237A5 (OSRAM)
JP2015511232A5 (OSRAM)
JP2011513410A5 (OSRAM)
JP2015504081A5 (OSRAM)
JP2015500842A5 (OSRAM)
JP2016531126A5 (OSRAM)
JP2016501844A5 (OSRAM)
JP2017517538A5 (OSRAM)